ArticleFrontiers in medical technology2026
Dissecting and stimulating instruments in thyroid surgery: principles, applications and clinical role.
Article in Frontiers in medical technology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Stimulating dissecting instruments (SDIs) combine fine dissection and calibrated nerve stimulation in a single tool, addressing the workflow limitations of conventional intermittent intraoperative neuromonitoring (IONM) in thyroid and parathyroid surgery. By eliminating repeated exchanges between a dissecting instrument and a separate stimulator, SDIs enable quasi-continuous functional assessment of the recurrent laryngeal nerve (RLN) and external branch of the superior laryngeal nerve (EBSLN) precisely during high-risk maneuvers, such as Berry's ligament dissection and superior pole management. Prospective clinical data in open thyroidectomy show that SDIs are feasible, safe, and effective in detecting early traction-related EMG changes, allowing timely release of stress and resulting in very low rates of postoperative RLN palsy, while experimental endoscopic and transoral models confirm reliable dose-response characteristics at clinically acceptable stimulation thresholds. In minimally invasive and narrow-corridor approaches, SDIs reduce instrument traffic and maintain neuromonitoring without disrupting operative flow, and their real-time feedback enhances training by directly linking dissection quality to neurophysiological signals. Within current guideline-based IONM frameworks, SDIs represent a practical evolution toward integrated, high-frequency monitoring, with future development expected to focus on their combination with energy-based devices, advanced imaging, and intelligent EMG analysis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.